Talimogene Laherparepvec (Imlygic®, T-VEC)
Pronounce: tal-IM-oh-jeen la-her-pa-REP-vek
Classification: Genetically Modified Oncolytic Viral Therapy
About Talimogene Laherparepvec (Imlygic®, T-VEC)
Talimogene laherparepvec is a genetically modified virus. It is a weakened version of the Herpes Simplex Virus Type 1, which can cause cold sores. It replicates within a tumor and produces a protein called GM-CSF that starts an immune response in your body. This causes the lysis (breakdown) of cancer cells.
How to Take Talimogene Laherparepvec
Talimogene laherparepvec is injected directly into a tumor that can be seen or felt by your provider. It can also be injected into a tumor that is found with ultrasound guidance. The dose depends on the number of tumors being treated and the size of those tumors.
This medication should not be used in patients who are pregnant or have a compromised immune system from HIV, AIDS, blood or bone marrow cancer, autoimmune disease, or who are being treated with steroids. The effectiveness of talimogene laherparepvec can be affected by anti-viral medications, such as acyclovir.
How to Administer Talimogene Laherparepvec
The area to be injected will be cleaned with an alcohol swab and given time to dry. The site may be treated with a numbing medication. A needle with the medication will be inserted into the tumor. The medication is then injected. The needle may be moved around to inject the full dose into different parts of the tumor. This will be repeated for each tumor being treated. The needle will be removed slowly and pressure will be held on the injection site with sterile gauze for at least 30 seconds. The area will be cleaned with alcohol and covered with a sterile dressing.
The site should remain covered with an airtight and watertight dressing for at least the first week after each treatment, or longer if the site is weeping or oozing. Avoid touching or scratching the injection site. Wash your hands well with soap and water before and after touching the injection site or dressings. All dressings and cleaning materials should be thrown out in a sealed plastic bag, in with your household trash.
Accidental exposure to talimogene laherparepvec can lead to herpes infection. Caregivers should wear gloves when helping with changing dressings or if there is a chance they may touch fluid from the tumor site. If their skin touches the soiled dressings or drainage, they should clean the area well with soap and water. Immunocompromised persons and pregnant women should not come in contact with the medication or any soiled materials.
Possible Side Effects of Talimogene Laherparepvec
There are a number of things you can do to manage the side effects of talimogene laherparepvec. Talk to your provider about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
Fatigue
Fatigue is very common during cancer treatment and is an overwhelming feeling of exhaustion that is not usually relieved by rest. While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities. Exercise can help combat fatigue; a simple daily walk with a friend can help. Talk to your provider for helpful tips on dealing with this side effect.
Flu-Like Symptoms
You may have fever, chills, aches, and pains. Your provider can recommend medication and other strategies to relieve these symptoms. This most often occurs during the first 3 months of treatment.
Injection Site Complications and Pain
The injection site should be kept clean and covered with an airtight and watertight dressing for at least 1 week after the injection. If the dressing becomes soaked through, the area should be cleaned and a new dressing applied. The injection site should be closely monitored for changes in color, warmth, pain, and leaking of excess fluid or pus. Notify your provider of any of these symptoms as they could be signs of infection.
Herpes Infection
Because this medication contains the herpes virus, it can cause a herpes infection. Symptoms of a herpes infection are:
- Pain, burning, or tingling in a blister around the mouth, genitals, fingers, or ears.
- Eye pain, sensitivity, discharge from the eyes, and blurry vision.
- Weakness in the arms and legs.
- Extreme fatigue and drowsiness.
- Mental confusion.
If you, or anyone in close contact with you, has any of these symptoms, it is important to notify your provider to be evaluated.
Nausea and/or Vomiting
Talk to your provider so they can prescribe medications to help you manage nausea and vomiting. In addition, dietary changes may help. Avoid things that may worsen the symptoms, such as heavy or greasy/fatty, spicy or acidic foods (lemons, tomatoes, oranges). Try saltines, or ginger ale to lessen symptoms.
Call your provider if you are unable to keep fluids down for more than 12 hours or if you feel lightheaded or dizzy at any time.
Important but Less Common Side Effects
- Plasmacytoma: In clinical trials, the development of plasmacytoma in patients with co-existing multiple myeloma has occurred. Be sure your provider is aware if you have multiple myeloma, even if it is smoldering multiple myeloma.
- Obstructive Airway Disorder: The medication can cause breathing and airway problems if injected close to major airways.
- Immune-related problems: This medication affects your immune system. It may cause kidney problems, inflamed blood vessels (vasculitis), swelling of the lungs (pneumonitis), worsening skin problems (such as psoriasis and vitiligo). Tell your provider about any immune diseases you have.
Reproductive Concerns
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should talk with your provider before breastfeeding while receiving this medication.